INTERNATIONAL PATENT: CROSSPOINT THERAPEUTICS INC., 주식회사 크로스포인트테라퓨틱스 FILES APPLICATION FOR "ANTIBODY-DRUG CONJUGATE COMPRISING HUMAN ANTIBODY FC VARIANT AND USE THEREOF"

GENEVA, Oct. 14 -- CROSSPOINT THERAPEUTICS INC. ((Yeongcheon-dong) 1306ho, 13F, 593-8, Dongtangiheung-ro,Hwaseong-si,Gyeonggi-do 18469), 주식회사 크로스포인트테라퓨틱스 (경기도화성시동탄기흥로 593-8, 13층 1306호 (영천동)) filed a patent application (PCT/KR2025/004610) for "ANTIBODY-DRUG CONJUGATE COMPRISING HUMAN ANTIBODY FC VARIANT AND USE THEREOF" on Apr 04, 2025. With publication no. WO/2025/211876, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Cla...